Us BCG Vaccine for Intradermal Injection Market: How Demographic Changes are Impacting Demand
BCG Vaccine for Intradermal Injection Market was valued at USD 0.65 Billion in 2022 and is projected to reach USD 1.10 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
The Bacillus Calmette-Guérin (BCG) vaccine, primarily used to prevent tuberculosis (TB), has been a cornerstone in global immunization programs since its first medical use in 1921. In the United States, the BCG vaccine is not commonly administered due to the relatively low prevalence of TB. However, it remains a critical tool in specific high-risk populations and certain medical treatments.
Market Overview
Globally, the BCG vaccine market was valued at approximately USD 98.15 million in 2022, with projections indicating growth at a Compound Annual Growth Rate (CAGR) of 5.17% from 2023 to 2030. This growth is driven by the rising prevalence of tuberculosis in certain regions, technological advancements in vaccine research and development, and increased government initiatives for vaccination campaigns. In the U.S., the market dynamics differ due to the lower incidence of TB, leading to more targeted vaccine administration.
Applications in the United States
- Bladder Cancer Treatment: The BCG vaccine is utilized as an intravesical therapy for non-muscle invasive bladder cancer. It has been effective in reducing the recurrence of tumors and is a standard treatment option in urology.
- High-Risk TB Exposure: In rare cases, the BCG vaccine is recommended for individuals continually exposed to untreated or ineffectively treated TB patients, particularly when the strains are resistant to isoniazid and rifampin.
Market Drivers
- Technological Advancements: Ongoing research into recombinant BCG vaccines aims to enhance efficacy and broaden protective effects, potentially leading to increased adoption in the future.
- Government Initiatives: Programs focusing on TB prevention and control, including potential vaccination strategies for high-risk groups, contribute to market dynamics.
Challenges
- Low TB Incidence: The United States' relatively low TB rates result in limited routine use of the BCG vaccine, affecting market size.
- Vaccine Supply and Demand: Manufacturing prioritization of other vaccines, such as those for COVID-19, has previously led to BCG vaccine shortages, impacting availability for both TB prevention and bladder cancer treatment.
Personal Insights
In my experience as a healthcare professional, the application of the BCG vaccine in bladder cancer therapy has been invaluable. Patients undergoing BCG treatment often experience a significant reduction in tumor recurrence, underscoring the vaccine's therapeutic importance beyond TB prevention. However, discussions with colleagues reveal concerns about vaccine availability, especially during global health crises that strain manufacturing capacities.
Future Outlook
While the routine use of the BCG vaccine for TB prevention remains limited in the U.S., its critical role in bladder cancer treatment and potential applications in other areas present opportunities for market growth. Continued investment in research, coupled with strategies to ensure consistent vaccine supply, will be essential in addressing both current and emerging healthcare needs.
Get an In-Depth Research Analysis of the Global BCG Vaccine for Intradermal Injection Market Size And Forecast [2025-2032]
Who are the largest Global manufacturers in the BCG Vaccine for Intradermal Injection Market?
- Merck
- Sanofi Pasteur
- Japan BCG Lab
- Shanghai Institute of Biological Products
- Serum Institute of India
- Intervax
- GSBPL
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global BCG Vaccine for Intradermal Injection Market Size And Forecast [2025-2032]
What are the factors driving the growth of the Global BCG Vaccine for Intradermal Injection Market?
Growing demand for below applications around the world has had a direct impact on the growth of the Global BCG Vaccine for Intradermal Injection Market
By Product Type
- Live Attenuated BCG Vaccine
- Recombinant BCG Vaccine
- BCG Vaccine Combination Products
By Application
- BCG Therapy for Bladder Cancer
- Immunomodulation in Other Cancer Types
- Prevention of Tuberculosis
By End-user
- Hospitals
- Outpatient Surgical Centers
- Research Laboratories
- Pharmaceutical Companies
By Delivery Method
- Intradermal Injection
- Subcutaneous Injection
By Formulation Type
- Suspension Formulation
- Lyophilized Formulation
- Solution Formulation
Which regions are leading the Global BCG Vaccine for Intradermal Injection Market?
- Global (United States, Global and Mexico)
- Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
- South America (Brazil, Argentina, Columbia, etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ BCG Vaccine for Intradermal Injection Market Research Analysis
Detailed TOC of Global BCG Vaccine for Intradermal Injection Market Research Report, 2024-2032
1. Introduction of the Global BCG Vaccine for Intradermal Injection Market
- Overview of the Market
- Scope of Report
- Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
- Data Mining
- Validation
- Primary Interviews
- List of Data Sources
4. Global BCG Vaccine for Intradermal Injection Market Outlook
- Overview
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porters Five Force Model
- Value Chain Analysis
5. Global BCG Vaccine for Intradermal Injection Market, By Type
6. Global BCG Vaccine for Intradermal Injection Market, By Application
7. Global BCG Vaccine for Intradermal Injection Market, By Geography
- Global
- Europe
- Asia Pacific
- Rest of the World
8. Global BCG Vaccine for Intradermal Injection Market Competitive Landscape
- Overview
- Company Market Ranking
- Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768